Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Dermatologic 1

Conditions

Multiple Myeloma 192Lymphoma 102Lymphoma, Non-Hodgkin 90Leukemia, Myeloid, Acute 89Precursor Cell Lymphoblastic Leukemia-Lymphoma 81Myelodysplastic Syndromes 81Hodgkin Disease 67Leukemia 66Neoplasms, Plasma Cell 65Lymphoma, Large B-Cell, Diffuse 59Leukemia, Lymphocytic, Chronic, B-Cell 58Lymphoma, Mantle-Cell 52Lymphoma, Follicular 49Burkitt Lymphoma 39Lymphoma, Large-Cell, Immunoblastic 35Lymphoma, B-Cell, Marginal Zone 34Myeloproliferative Disorders 30Recurrence 28Hematologic Neoplasms 28Neuroblastoma 25Leukemia, Myelogenous, Chronic, BCR-ABL Positive 25Leukemia, Myeloid, Accelerated Phase 24Graft vs Host Disease 23Leukemia, Myelomonocytic, Chronic 22Leukemia, Myeloid, Chronic-Phase 22Congenital Abnormalities 21Immunoglobulin Light-chain Amyloidosis 20Dendritic Cell Sarcoma, Interdigitating 19Primary Myelofibrosis 18Waldenstrom Macroglobulinemia 17

Interventions

Nivolumab 13Ipilimumab 10pembrolizumab 8cemiplimab 6Surveys and Questionnaires 6Biopsy 6aldesleukin 5Radiotherapy 5Interleukin-2 5Blood Specimen Collection 5Temozolomide 4Sirolimus 4Photochemotherapy 4Mohs Surgery 4HhAntag691 4Fluorouracil 4Educational Status 4Cyclophosphamide 4sonidegib 3fludarabine phosphate 3fludarabine 3avelumab 3Vemurafenib 3Surgical Procedures, Operative 3Radiation 3Petrolatum 3Cetuximab 3Aminolevulinic Acid 3trametinib 2dabrafenib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Skin Neoplasms × Melphalan × Clear all
NCT02507076 2015-07-23

Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma

Albert Einstein College of Medicine

Phase NA Withdrawn
DermatologicSarcoma

Carcinoma, Basal Cell, Melanoma, Sarcoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡